Sage Journals: Discover world-class research

Open access

Research article

First published 2015

Cisplatin,Cetuximab,and Radiation in Locally Advanced Head and Neck Squamous Cell Cancer: A Retrospective Review

Prakash Peddi, Runhua Shi, Binu Nair [...]

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2013-9

Cetuximab hypersensitivity infusion reactions: Incidence and risk factors *

Sarah Hopps, Patrick Medina, Shubham Pant [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2017-3

Reporting on Adverse Clinical Events

Clin-Alert

Retricted access

Research article

First published 2008-03

Reporting On Adverse Clinical Events

Clin-Alert

Retricted access

Research article

First published 2007-12

Biological Activity In Vitro of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies with Different Affinities

Arlhee Diaz Miqueli, Rances Blanco, Beatriz Garcia [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Retricted access

Research article

First published 2016-2

Analysis of 473 US Head and Neck Cancer Trials (1996-2014)

Anand Devaiah, Charles Murchison

Otolaryngology–Head and Neck Surgery

Open access

Research article

First published 2021

Cetuximab–siRNA Conjugate Linked Through Cationized Gelatin Knocks Down KRAS G12C Mutation in NSCLC Sensitizing the Cells Toward Gefitinib

K. Sreedurgalakshmi, R. Srikar, K. Harikrishnan [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 2025-3

Reporting on Adverse Clinical Events

Clin-Alert

Open access

Research article

First published 2019

Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers

Gemma Bruera, Silvia Massacese, Francesco Pepe [...]

Therapeutic Advances in Medical Oncology

Search results